Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
38.93 USD | +0.10% | +1.06% | +1.11% |
08/05 | Stifel Cuts Price Target on Astrana Health to $45 From $50, Maintains Buy Rating | MT |
07/05 | Transcript : Astrana Health, Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.11% | 1.9B | |
+17.20% | 85.55B | |
-28.25% | 70.07B | |
+6.76% | 28.95B | |
-7.33% | 17.51B | |
+2.14% | 17.39B | |
+1.86% | 15.38B | |
+6.95% | 13.4B | |
+65.69% | 12.93B | |
+6.64% | 12.77B |
- Stock Market
- Equities
- ASTH Stock
- News Astrana Health, Inc.
- Truist Initiates Apollo Medical With Hold Rating, Price Target is $41